Hans L. Bock

2.1k total citations
76 papers, 1.7k citations indexed

About

Hans L. Bock is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Hans L. Bock has authored 76 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 28 papers in Infectious Diseases and 27 papers in Microbiology. Recurrent topics in Hans L. Bock's work include Bacterial Infections and Vaccines (27 papers), Pneumonia and Respiratory Infections (22 papers) and Hepatitis Viruses Studies and Epidemiology (20 papers). Hans L. Bock is often cited by papers focused on Bacterial Infections and Vaccines (27 papers), Pneumonia and Respiratory Infections (22 papers) and Hepatitis Viruses Studies and Epidemiology (20 papers). Hans L. Bock collaborates with scholars based in Belgium, United Kingdom and Singapore. Hans L. Bock's co-authors include Htay Htay Han, Yong Poovorawan, Voranush Chongsrisawat, Irving Charles Boudville, Ralf Clemens, Yanee Hutagalung, Haïwen Tang, Bee Wah Lee, Kong Boo Phua and Seng Hock Quak and has published in prestigious journals such as The Journal of Infectious Diseases, The Journal of Pediatrics and Vaccine.

In The Last Decade

Hans L. Bock

75 papers receiving 1.6k citations

Peers

Hans L. Bock
Marie Van der Wielen Belgium
Vytautas Usonis Lithuania
Rodrigo DeAntonio Panama
Edward Rothstein United States
H.L. Bock Germany
Margaret B. Rennels United States
Maria Moriondo Italy
Leonard R. Friedland United States
Luc Hessel France
Aino Karvonen Finland
Marie Van der Wielen Belgium
Hans L. Bock
Citations per year, relative to Hans L. Bock Hans L. Bock (= 1×) peers Marie Van der Wielen

Countries citing papers authored by Hans L. Bock

Since Specialization
Citations

This map shows the geographic impact of Hans L. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans L. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans L. Bock more than expected).

Fields of papers citing papers by Hans L. Bock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans L. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans L. Bock. The network helps show where Hans L. Bock may publish in the future.

Co-authorship network of co-authors of Hans L. Bock

This figure shows the co-authorship network connecting the top 25 collaborators of Hans L. Bock. A scholar is included among the top collaborators of Hans L. Bock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans L. Bock. Hans L. Bock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tallo, Veronica, et al.. (2015). THE BURDEN OF INVASIVE NEONATAL GROUP B STREPTOCOCCAL (GBS) DISEASE IN THAILAND AND THE PHILIPPINES.. PubMed. 46(4). 728–37. 11 indexed citations
2.
Phua, Kong Boo, et al.. (2013). A Hospital-based Surveillance of Rotavirus Gastroenteritis in Children <5 Years of Age in Singapore. The Pediatric Infectious Disease Journal. 32(12). e426–e431. 10 indexed citations
3.
Lau, YL, E. Anthony S. Nelson, Paul K.S. Chan, et al.. (2013). Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial. Vaccine. 31(18). 2253–2259. 23 indexed citations
4.
Lin, Tzou‐Yien, Chun‐Yi Lu, Luan‐Yin Chang, et al.. (2012). Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan. Journal of the Formosan Medical Association. 111(9). 495–503. 11 indexed citations
5.
Burgess, Margaret A, Peter McIntyre, Margaret Hellard, et al.. (2010). Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine. 28(10). 2222–2226. 17 indexed citations
6.
Bhatla, Neerja, Vanita Suri, Partha Basu, et al.. (2010). Immunogenicity and safety of human papillomavirus‐16/18 AS04‐adjuvanted cervical cancer vaccine in healthy Indian women. Journal of obstetrics and gynaecology research. 36(1). 123–132. 42 indexed citations
7.
8.
Poovorawan, Yong, Voranush Chongsrisawat, Apiradee Theamboonlers, et al.. (2009). Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine. 28(3). 730–736. 91 indexed citations
9.
Datta, Sanjoy, Neerja Bhatla, Margaret Burgess, Matti Lehtinen, & Hans L. Bock. (2009). Women and vaccinations: From smallpox to the future, a tribute to a partnership benefiting humanity for over 200 years. Human Vaccines. 5(7). 450–454. 2 indexed citations
10.
Poovorawan, Yong, Voranush Chongsrisawat, Apiradee Theamboonlers, et al.. (2009). Long‐Term Benefit of Hepatitis B Vaccination among Children in Thailand with Transient Hepatitis B Virus Infection Who Were Born to Hepatitis B Surface Antigen–Positive Mothers. The Journal of Infectious Diseases. 200(1). 33–38. 36 indexed citations
11.
Narang, Anil, Anuradha Bose, A N Pandit, et al.. (2009). Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Human Vaccines. 5(6). 414–419. 60 indexed citations
12.
Saha, Samir K., et al.. (2009). Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh. World Journal of Gastroenterology. 15(39). 4932–4932. 24 indexed citations
13.
Phua, Kong Boo, Seng Hock Quak, Fong Seng Lim, et al.. (2008). Immunogenicity, Reactogenicity and Safety of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Polio and Haemophilus Influenzae Type b Combination Vaccine in a Placebo-controlled Rotavirus Vaccine Study. Annals of the Academy of Medicine Singapore. 37(7). 546–553. 20 indexed citations
14.
Wilder‐Smith, Annelies, et al.. (2007). Knowledge, Attitude, and Practices With Regard to Adult Pertussis Vaccine Booster in Travelers. Journal of Travel Medicine. 14(3). 145–150. 15 indexed citations
15.
Bock, Hans L., et al.. (2006). Does the Concurrent Administration of an Inactivated Hepatitis A Vaccine Influence the Immune Response to Other Travelers Vaccines?. Journal of Travel Medicine. 7(2). 74–78. 2 indexed citations
16.
Bock, Hans L., et al.. (2006). Reactogenicity and Immunogenicity Profiles of a Novel Pentavalent Diphtheria-Tetanus???Whole Cell Pertussis???Hepatitis B and Haemophilus Influenzae Type B Vaccine. The Pediatric Infectious Disease Journal. 25(8). 706–712. 13 indexed citations
17.
Schmitt, Heinz-J., Karin Beutel, Anne Schuind, et al.. (1997). Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. The Journal of Pediatrics. 130(4). 616–623. 54 indexed citations
18.
Bock, Hans L., Thomas Löscher, N. Scheiermann, et al.. (1995). Accelerated Schedule for Hepatitis B Immunization. Journal of Travel Medicine. 2(4). 213–217. 47 indexed citations
19.
Clemens, Ralf, Sasithon Pukrittayakamee, S Vanijanonta, et al.. (1995). Therapeutic effects of antivenom supplemented by antithrombin III in rats experimentally envenomated with Russell's viper (Daboia russelli siamensis) venom. Toxicon. 33(1). 77–82. 3 indexed citations
20.
Bock, Hans L., et al.. (1988). Active and passive rabies immunization: The effect of administering hyperimmune globulin before the vaccine. Journal of Biological Standardization. 16(1). 67–69. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Van der Wielen Breakdown of academic impact, for papers by Vytautas Usonis Breakdown of academic impact, for papers by Rodrigo DeAntonio Breakdown of academic impact, for papers by Edward Rothstein Breakdown of academic impact, for papers by H.L. Bock Breakdown of academic impact, for papers by Margaret B. Rennels Breakdown of academic impact, for papers by Maria Moriondo Breakdown of academic impact, for papers by Leonard R. Friedland Breakdown of academic impact, for papers by Luc Hessel Breakdown of academic impact, for papers by Aino Karvonen
Rankless by CCL
2026